Human Pathology
Volume 41, Issue 3 , Pages 366-374 , March 2010

Lymphatic and blood vessels in scleroderma skin, a morphometric analysis

  • Antonella Rossi, PhD

      Affiliations

    • Department of Neuroscience, Section of Molecular Medicine, University of Siena, Via Aldo Moro, 53100 Siena, Italy
    • ,
  • Francesca Sozio, MS

      Affiliations

    • Department of Neuroscience, Section of Molecular Medicine, University of Siena, Via Aldo Moro, 53100 Siena, Italy
    • ,
  • Piersante Sestini, MD

      Affiliations

    • Department of Clinical Medicine and Immunological Sciences, Section of Respiratory Diseases, University of Siena, 53100 Siena, Italy
    • ,
  • Elisabetta A. Renzoni, MD

      Affiliations

    • Interstitial Lung Disease Unit, Royal Brompton Hospital, National Heart and Lung Institute, Imperial College of Science, Technology and Medicine, SW3 6LR London, UK
    • ,
  • Korsa Khan, BSc

      Affiliations

    • Centre for Rheumatology and Connective Tissue Diseases, UCL Medical School, NW3 2PN London, UK
    • ,
  • Christopher P. Denton, MD, PhD

      Affiliations

    • Centre for Rheumatology and Connective Tissue Diseases, UCL Medical School, NW3 2PN London, UK
    • ,
  • David J. Abraham, PhD

      Affiliations

    • Centre for Rheumatology and Connective Tissue Diseases, UCL Medical School, NW3 2PN London, UK
    • ,
  • Elisabetta Weber, MD

      Affiliations

    • Department of Neuroscience, Section of Molecular Medicine, University of Siena, Via Aldo Moro, 53100 Siena, Italy
    • Corresponding Author InformationCorresponding author. Dipartimento di Neuroscienze, Sezione di Medicina Molecolare, University of Siena, Via Aldo Moro, 53100 Siena, Italy.

Received 29 April 2009 ,Revised 28 July 2009 ,Accepted 4 August 2009.

References 

  1. Fleming JN, Schwartz SM. The pathology of scleroderma vascular disease. Rheum Dis Clin North Am. 2008;34:41–55
  2. Varga J, Abraham D. Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest. 2007;117:557–567
  3. Claman HN, Giorno RC, Seibold JR. Endothelial and fibroblastic activation in scleroderma. The myth of the “uninvolved skin”. Arthritis Rheum. 1991;34:1495–1501
  4. LeRoy EC. Systemic sclerosis. A vascular perspective. Rheum Dis Clin North Am. 1996;22:675–694
  5. Abraham D, Distler O. How does endothelial cell injury start? The role of endothelin in systemic sclerosis. Arthritis Res Ther. 2007;9:S2
  6. Kallenberg CG. Early detection of connective tissue disease in patients with Raynaud's phenomenon. Rheum Dis Clin North Am. 1990;16:11–30
  7. Cutolo M, Pizzorni C, Tuccio M, et al. Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis. Rheumatology. 2004;43:719–726
  8. Distler O, Distler JH, Scheid A, et al. Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosis. Circ Res. 2004;95:109–116
  9. Choi JJ, Min DJ, Cho ML, et al. Elevated vascular endothelial growth factor in Systemic Sclerosis. J Rheumatol. 2003;30:1529–1533
  10. Distler O, Del Rosso A, Giacomelli R, et al. Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers. Arthritis Res. 2002;4:R11
  11. Dor Y, Djonov V, Abramovitch R, et al. Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy. EMBO J. 2002;21:1939–1947
  12. Kahaleh B, Meyer O, Scorza R. Assessment of vascular involvement. Clin Exp Rheumatol. 2003;21:S9–S14
  13. Cueni LN, Detmar M. New insights into the molecular control of the lymphatic vascular system and its role in disease. J Invest Dermatol. 2006;126:2167–2177
  14. Jackowski S, Janusch M, Fiedler E, et al. Radiogenic lymphangiogenesis in the skin. Am J Pathol. 2007;171:338–348
  15. Kajiya K, Kunstfeld R, Detmar M, Chung JH. Reduction of lymphatic vessels in photodamaged human skin. J Dermatol Sci. 2007;47:241–243
  16. Kahn HJ, Marks AA. new monoclonal antibody, D2-40, for detection of lymphatic invasion in primary tumors. Lab Invest. 2002;82:1255–1257
  17. Schacht V, Dadras SS, Johnson LA, Jackson DG, Hong YK, Detmar M. Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. Am J Pathol. 2005;166:913–921
  18. Kunstfeld R, Hirakawa S, Hong YK, et al. Induction of cutaneous delayed-type hypersensitivity reactions in VEGF-A transgenic mice results in chronic skin inflammation associated with persistent lymphatic hyperplasia. Blood. 2004;104:1048–1057
  19. Ji RC, Miura M, Qu P, Kato S. Expression of VEGFR-3 and 5′-Nase in regenerating lymphatic vessels of the cutaneous wound healing. Microsc Res Tech. 2004;64:279–286
  20. Oka M, Iwata C, Suzuki HI, et al. Inhibition of endogenous TGF-beta signaling enhances lymphangiogenesis. Blood. 2008;111:4571–4579
  21. Clavin NW, Avraham T, Fernandez J, et al. TGF-beta1 is a negative regulator of lymphatic regeneration during wound repair. Am J Physiol Heart Circ Physiol. 2008;295:H2113–H2127
  22. Leu AJ, Gretener SB, Enderlin S, et al. Lymphatic microangiopathy of the skin in systemic sclerosis. Rheumatology (Oxford). 1999;38:221–227
  23. LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis) classification, subsets and pathogenesis. J Rheumatol. 1988;15:202–205
  24. In:  West BT,  Welch BT,  Gatecki AT editor. Linear mixed models. A practical guide using statistical software. Boca Raton (Fla): Chapman and Hall/CRC; 2007;p. 353
  25. Ryan T. The ageing of the blood supply and the lymphatic drainage of the skin. Micron. 2004;35:161–171
  26. Pruim B, Strutton G, Congdon S, Whitehead K, Donaldson E. Cutaneous histiocytic lymphangitis: an unusual manifestation of rheumatoid arthritis. Australas J Dermatol. 2000;41:101–105
  27. Takiwaki H, Adachi A, Kohno H, Ogawa Y. Intravascular or intralymphatic histiocytosis associated with rheumatoid arthritis: a report of 4 cases. J Am Acad Dermatol. 2004;50:585–590
  28. Tanaka T, Damião AO, Gabriel Júnior A, et al. Protein-losing enteropathy in systemic lupus erythematosus. Rev Hosp Clin Fac Med Sao Paulo. 1991;46:34–37
  29. Ibba-Manneschi L, Niissalo S, Milia AF, et al. Variation of neuronal nitric oxide synthase in systemic sclerosis skin. Arthritis Rheum. 2006;54:202–213
  30. Fleming JN, Nash RA, McLeod DO, et al. Capillary regeneration in scleroderma: stem cell therapy reverses phenotype?. PLoS ONE. 2008;e1452:3
  31. Kahaleh B. Vascular disease in scleroderma: mechanisms of vascular injury. Rheum Dis Clin North Am. 2008;34:57–71
  32. Mulligan-Kehoe MJ, Simons M. Vascular disease in scleroderma: angiogenesis and vascular repair. Rheum Dis Clin North Am. 2008;34:73–79
  33. Kuwana M, Okazaki Y, Yasuoka H, Kawakami Y, Ikeda Y. Defective vasculogenesis in systemic sclerosis. Lancet. 2004;364:603–610
  34. Del Papa N, Quirici N, Soligo D, et al. Bone marrow endothelial progenitors are defective in systemic sclerosis. Arthritis Rheum. 2006;54:2605–2615
  35. Gomer RH. Circulating progenitor cells and scleroderma. Curr Rheumatol Rep. 2008;10:183–188
  36. Ryan TJ. Structure and functions of lymphatics. J Invest Dermatol. 1989;93:18S–24S
  37. Adams RH, Alitalo K. Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol. 2007;8:464–478
  38. Chitale S, Al-Mowallad AF, Wang Q, Kumar S, Herrick A. High circulating levels of VEGF-C suggest abnormal lymphangiogenesis in systemic sclerosis. Rheumatology (Oxford). 2008;47:1727–1728
  39. Mackiewicz Z, Sukura A, Povilenaité D, et al. Increased but imbalanced expression of VEGF and its receptors has no positive effect on angiogenesis in systemic sclerosis skin. Clin Exp Rheumatol. 2002;20:641–646
  40. Asahara T, Masuda H, Takahashi T, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res. 1999;85:221–228
  41. Religa P, Cao R, Bjorndahl M, et al. Presence of bone marrow-derived circulating progenitor endothelial cells in the newly formed lymphatic vessels. Blood. 2005;106:4184–4190

 This work was supported by PAR grants of the University of Siena, and the Arthritis Research Campaign, UK.

PII: S0046-8177(09)00296-2

doi: 10.1016/j.humpath.2009.08.009

Human Pathology
Volume 41, Issue 3 , Pages 366-374 , March 2010

Article Tools

* Image Usage & Resolution